Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+.
about
L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study.Characteristics of L-citrulline transport through blood-brain barrier in the brain capillary endothelial cell line (TR-BBB cells).Cerebral haemodynamics in patients with glutaryl-coenzyme A dehydrogenase deficiency.In vitro study of uptake and synthesis of creatine and its precursors by cerebellar granule cells and astrocytes suggests some hypotheses on the physiopathology of the inherited disorders of creatine metabolism.Neuropsychological profile and clinical effects of arginine treatment in children with creatine transport deficiency.Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.Effect of pluronic p85 on amino acid transport in bovine brain microvessel endothelial cells18F-AFETP, 18F-FET, and 18F-FDG imaging of mouse DBT gliomas.The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood-brain barrier in vitro.Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disorders.Brain-kidney crosstalk.Possible sources and functions of L-homoarginine in the brain: review of the literature and own findings.Solute Carriers in the Blood-Brain Barier: Safety in Abundance.Blood-brain barrier transport machineries and targeted therapy of brain diseases.Cationic amino acid transporter 1-mediated L-arginine transport at the inner blood-retinal barrier.The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain.Metabolic Differences between Dogs of Different Body Sizes.Effects of time of L-ornithine administration on the diurnal rhythms of plasma growth hormone, melatonin, and corticosterone levels in mice.Treatment with L-arginine improves neuropsychological disorders in a child with creatine transporter defect.Orally administered L-ornithine elevates brain L-ornithine levels and has an anxiolytic-like effect in mice.Serum amino acid profile in patients with Parkinson's disease.Differential topochemistry of three cationic amino acid transporter proteins, hCAT1, hCAT2 and hCAT3, in the adult human brain.Chronic postnatal ornithine administration to rats provokes learning deficit in the open field task.Development and characterization of lysine-methotrexate conjugate for enhanced brain delivery.Elucidating molecular mechanisms of the developmental origins hypothesis: p53 phosphorylation, apoptosis, and nephrogenesis.New insights in staging and chemotherapy of African trypanosomiasis and possible contribution of medicinal plants.Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier
P2860
Q30475497-EACA300A-6B62-43C9-9DDE-CA7C42426031Q33655373-BF809482-8EC4-4755-86F3-E654CF93D79AQ34020678-2D474DDE-4862-4F5A-A6FD-828DE17CAFF6Q34247638-CEB8347C-A59C-4DB1-86E9-A6674AC43014Q36478674-9FC2BCFD-38F8-4DE4-A4DE-745D0747A138Q36740553-98B2D8D1-D637-4FC3-A2A9-9500B26AA849Q37101429-2589EB90-3700-4668-898C-1778E30D5333Q37155873-F3503104-1C1D-40C8-8B93-6AEDE0734BE1Q37296720-1CA5C97D-A2F5-4AC5-BAB6-5729DD24AFF7Q37847248-D75331BE-46F6-4A24-9480-1B08B644B7BEQ38231896-F514EADC-84D9-450C-9E4F-5D47C6BFC295Q38384628-2B0DBA27-981D-4978-8225-48E8288D21E6Q38922312-D761FD09-5EAD-4088-AC90-7267430AD498Q39164804-ADA1126A-D835-420A-89D8-0E05D6703AEAQ39807366-2A46B1B3-53AA-4D4C-AEA9-E3FF96A7E04CQ41502922-FA250E2E-C4FF-4BEC-A5C9-A4B302483FF8Q46026460-6B082B61-CBA2-4ACE-95F2-B6C0DE065D1FQ46437567-F14CE7CA-645A-4A04-AA70-334CA3859138Q46527196-B66F9385-515D-4B41-920F-911B672A7D1BQ48031722-9F808F6F-4E1E-4443-B856-3266325A93CAQ48043375-B46D72C1-4647-4EE5-A0E6-D3F275FFA4C5Q48417317-096DB16B-7534-43AE-9C1B-1637B077A078Q48472833-AAA36EF9-150C-493D-8833-3F441FD36CD5Q48477765-829D1177-BAFB-4DB6-83B3-336AF23F0BDAQ52009670-E1E22B31-7B4C-4651-9B63-AD4BB5FB98EDQ53906272-E9778807-7A37-47D1-81FE-14B22F827288Q57810063-4D81775D-3CCB-4340-BAB2-F2EDF3AE9645
P2860
Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Cationic amino acid transport ...... ated exclusively by system y+.
@en
Cationic amino acid transport ...... ated exclusively by system y+.
@nl
type
label
Cationic amino acid transport ...... ated exclusively by system y+.
@en
Cationic amino acid transport ...... ated exclusively by system y+.
@nl
prefLabel
Cationic amino acid transport ...... ated exclusively by system y+.
@en
Cationic amino acid transport ...... ated exclusively by system y+.
@nl
P2093
P2860
P1476
Cationic amino acid transport ...... ated exclusively by system y+.
@en
P2093
Ashwini Mokashi
Ian Simpson
Juan R Viña
Richard A Hawkins
Robyn L O'Kane
Rosa Zaragozá
P2860
P304
P356
10.1152/AJPENDO.00007.2006
P577
2006-03-28T00:00:00Z